|
[1]TIAN XL,LI Y.Endothelial cellsenescenceand age-related vascular diseases[J].J Genet Genomics,2014,41(9):485-495.
|
|
[2]PALMER AK,TCHKONIA T,LEBRASSEUR NK,et al.Cellularsenescencein type 2 diabetes:a therapeutic opportunity[J].Diabetes,2015,64(7):2289-2298.
|
|
[3]HOARE M,DAS T,LEXANDER G.Ageing,telomeres,senescence,and liver injury[J].J Hepatol,2010,53(5):950-961.
|
|
[4]CAMPISI J.Aging,cellular senescence,and cancer[J].Annu Rev Physiol,2013,75:685-705.
|
|
[5]TAKEUCHI S,TAKAHASHI A,MOTOI N,et al.Intrinsic cooperation betweenp16INK4a and p21Waf1/Cip1in the onset of cellular senescence and tumor suppression in vivo[J].Cancer Res,2010,70(22):9381-9390.
|
|
[6]CAMPISI J,ROBERT L.Cellsenescence:role inagingand age-related diseases[J].Interdiscip Top Gerontol,2014,39:45-61.
|
|
[7]COPPE JP,DESPREZ PY,KRTOLICA A,et al.The senescence-associated secretory phenotype:the dark side of tumor suppression[J].Annu Rev Pathol,2010,5:99-118.
|
|
[8]KOSAR M,BARTKOVA J,HUBACKOVA S,et al.Senescenceassociated heterochromatin foci are dispensable for cellular senescence,occur in a cell type-and insult-dependent manner,and follow expression of p16(ink4a)[J].Cell Cycle,2011,10(3):457-468.
|
|
[9]KRIZHANOVSKY V,YON M,DICKINS RA,et al.Senescence of activated stellate cells limits liver fibrosis[J].Cell,2008,134(4):657-667.
|
|
[10]KLEIN S,KLSEL J,SCHIERWAGEN R,et al.Atorvastatin inhibits proliferation and apoptosis,but inducessenescencein hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats[J].Lab Invest,2012,92(10):1440-1450.
|
|
[11]KONG X,FENG D,WANG H,et al.Interleukin-22 induces hepatic stellate cellsenescenceand restrictsliverfibrosis in mice[J].Hepatology,2012,56(3):1150-1159.
|
|
[12]NAKAJIMA T,NAKASHIMA T,OKADA Y,et al.Nuclear size measurement is a simple method for the assessment of hepatocellular aging in non-alcoholic fatty liver disease:comparison with telomere-specific quantitative FISH and p21 immunohistochemistry[J].Pathol Int,2010,60(3):175-183.
|
|
[13]ARAVINTHAN A,SCARPINI C,TACHTATZIS P,et al.Hepatocyte senescence predicts in non-alcohol-related fatty liver disease[J].J Hepatol,2013,58(3):549-556.
|
|
[14]CARULLI L,DEI CAS A,NASCIMBENI F.Synchronous cryptogenic liver cirrhosis and idiopathic pulmonary fibrosis:a clue to telomere involvement[J].Hepatology,2012,56(5):2001-2003.
|
|
[15]CHAITEERAKIJ R,ROBERTS LR.Telomerasemutation:ageneticrisk factor for cirrhosis[J].Hepatology,2011,53(5):1430-1432.
|
|
[16]CARULLI L,ANZIVINO C.Telomere and telomerase in chronic liver disease and hepatocarcinoma[J].World J Gastroenterol,2014,20(20):6287-6292.
|
|
[17]SASAKI M,IKEDA H,YAMAGUCHI J,et al.Bile ductular cells undergoing cellular senescence increase in chronic liver diseases along with fibrous progression[J].Am J Clin Pathol,2010,133(2):212-223.
|
|
[18]SYN WK,JUNG Y,OMENETTI A,et al.Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease[J].Gastroenterology,2009,137(4):1478-1488.
|
|
[19]CHIBA M,SASAKI M,KITAMURA S,et al.Participation of bile ductular cells in the pathological progression of non-alcoholic fatty liver disease[J].J Clin Pathol,2011,64(7):564-570.
|
|
[20]VERMA S,TACHTATZIS P,PENRHYN-LOWE S,et al.Sustained telomere length in hepatocytes and cholangiocytes with increasing age in normal liver[J].Hepatology,2012,56(4):1510-1520.
|
|
[21]BAFFY G,BRUNT EM,CALDWELL SH.Hepatocellular carcinoma in non-alcoholic fatty liver disease:an emerging menace[J].J Hepatol,2012,56(6):1384-1391.
|
|
[22]ESPOSITO K,CHIODINI P,COLAO A,et al.Metabolic syndrome and risk of cancer:a systematic review and meta-analysis[J].Diabetes Care,2012,35(11):2402-2411.
|
|
[23]VANNI E,BUGIANESI E.Obesity and liver cancer[J].Clin Liver Dis,2014,18(1):191-203.
|
|
[24]DAVALOS AR,COPPE JP,CAMPISI J,et al.Senescent cells as a source of inflammatory factors for tumor progression[J].Cancer Metastasis Rev,2010,29(2):273-283.
|
|
[25]LABERGE RM,AWAD P,CAMPISI J,et al.Epithelial-mesenchymal transition induced by senescent fibroblasts[J].Cancer Microenviron,2012,5(1):39-44.
|
|
[26]COULON S,FRANCQUE S,COLLE I,et al.Evaluation of inflammatory and angiogenicfactorsin patients withnon-alcoholic fatty liver disease[J].Cytokine,2012,59(2):442-449.
|
|
[27]PARK EJ,LEE JH,YU GY.Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression[J].Cell,2010,140(2):197-208.
|
|
[28]YEVSA T,KANG TW,ZENDER L.Immune surveillance of pre-cancerous senescent hepatocytes limits hepatocellular carcinoma development[J].Oncoimmunology,2012,1(3):398-399.
|
|
[29]FREUND A,ORJALO AV,DESPREZ PY,et al.Inflammatory networks during cellular senescence:causes and consequences[J].Trends Mol Med,2010,16(5):238-246.
|
|
[30]YOSHIMOTO S,LOO TM,ATARASHI K,et al.Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome[J].Nature,2013,499(7456):97-101.
|
|
[31]CHEN SL,ZHENG MH,SHI KQ,et al.A new strategy for treatment of liver fibrosis letting microRNAs do the job[J].Bio Drugs,2013,27(1):25-34.
|
|
[32]Mc CLENDON AK,DEAN JL,ERTEL A,et al.Rb and p53 cooperate to prevent liver tumorigenesis in response to tissue damage[J].Gastroenterology,2011,141(4):1439-1450.
|
|
[33]DI J,ZHANG Y,ZHENG J.Reactivation of p53 by inhibiting Mdm2 E3ligase:a novel antitumor approach[J].Curr Cancer Drug Targets,2011,11(8):987-994.
|
|
[34]BAKER DJ,WIJSHAKE T,TCHKONIA T,et al.Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders[J].Nature,2011,479(7372):232-236.
|
DownLoad: